Milestone Pharmaceuticals CEO Joseph Oliveto's 2020 pay jumps 421% to $4.1M

Milestone Pharmaceuticals reports 2020 executive compensation

By ExecPay News

Published: April 30, 2021

Milestone Pharmaceuticals reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, three executives at Milestone Pharmaceuticals received on average a compensation package of $2.6M, a 113% increase compared to previous year.
Average pay of disclosed executives at Milestone Pharmaceuticals
Joseph Oliveto, Chief Executive Officer, received $4.1M in total, which increased by 421% compared to 2019. 84% of Oliveto's compensation, or $3.4M, was in option awards. Oliveto also received $165K in non-equity incentive plan, $470K in salary, as well as $12K in other compensation.
Amit Hasija, Chief Financial Officer, received a compensation package of $2M, which decreased by 19% compared to previous year. 78% of the compensation package, or $1.6M, was in option awards.
Francis Plat, Chief Medical Officer, earned $1.8M in 2020, a 213% increase compared to previous year.

Related executives

Joseph Oliveto

Milestone Pharmaceuticals

Chief Executive Officer

Amit Hasija

Milestone Pharmaceuticals

Chief Financial Officer

Francis Plat

Milestone Pharmaceuticals

Chief Scientific Officer

You may also like

Source: SEC filing on April 30, 2021.